Elevance Health's Small Outlook Boost Disappoints, Stock Sinks
Elevance Health Inc. (NYSE: ELV ) on Wednesday reported second-quarter results that topped Wall Street estimates and raised its full-year adjusted earnings and operating cash flow guidance, supported by higher premium yields and continued growth in its Carelon business. Adjusted earnings came in at $7.45 per share, bea